PB2133: ASSESSING SAFETY, TOLERABILITY, AND EFFICACY OF SUBCUTANEOUS EPCORITAMAB IN NOVEL COMBINATIONS WITH ANTI-NEOPLASTIC AGENTS IN PATIENTS WITH NON-HODGKIN LYMPHOMA IN A PHASE 1B/2, OPEN-LABEL STUDY

Bibliographic Details
Main Authors:	L. H. Sehn, I. Avivi, J. Brody, D. H. Yoon, B. M. Elliott, S. R. Siddani, Y. Bai, A. Parikh, M. M. Seliem, M. H. Dinh, A. P. Skarbnik
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000851364.83658.ec

Internet